LEAD DIRECTOR OF THE BOARD OF DIRECTORS POSITION DESCRIPTION
September 14, 2026
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
September 8, 2026
Canopy Growth Broadens Australian Medical Cannabis Portfolio with New Formats and Formulations
Canopy Growth Broadens Australia Medical Cannabis Portfolio with New Formats and Formulations
August 17, 2026
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed
August 14, 2026
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility (“Kincardine”) has received renewed European Union Good Manufacturing Practice
August 7, 2026
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
July 24, 2026
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
SMITHS FALLS, ON – July 24, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) will release its financial results for the first quarter fiscal year 2027 ended June 30, 2026 before financial markets open on August 7, 2026.
